Skip to main content
Clinical Trials/ACTRN12610000371099
ACTRN12610000371099
Active, Not Recruiting
N/A

A randomized trial to study whether neuromuscular effect of rocuronium is prolonged in patients with obstructive jaundice, in order to reduce the risk of postoperative residual neuromuscular block.

zhen-meng wang0 sites60 target enrollmentMay 10, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
patients with obstructive jaundice
Sponsor
zhen-meng wang
Enrollment
60
Status
Active, Not Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 10, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
zhen-meng wang

Eligibility Criteria

Inclusion Criteria

  • patients for upper abdominal surgery with or without obstructive jaundice

Exclusion Criteria

  • Age\<65 yr or \>18 yr; body mass index (BMI) \<24\.9 or \>18\.5; history of diabetes, cardiovascular, respiratory, or renal diseases; hepatic encephalopathy, psychiatric illnesses, or neuropathy; complication of acute cholangitis, gastrointestinal bleeding, or ascites; electrolyte or acid\-base disturbance, sepsis; receiving drugs known to interfere with neuromuscular transmission.

Outcomes

Primary Outcomes

Not specified

Similar Trials